143 related articles for article (PubMed ID: 28196090)
21. Recommendation of the use of myeloblast percentage among non-erythroid cells instead of percentage among total nucleated cells for therapeutic response assessment in acute erythroid leukemia.
Jun KR; Park CJ; Cho YW; Jang S; Chi HS; Lee JH; Lee KH
Leuk Lymphoma; 2006 Apr; 47(4):683-7. PubMed ID: 16690527
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.
Kowal-Vern A; Mazzella FM; Cotelingam JD; Shrit MA; Rector JT; Schumacher HR
Am J Hematol; 2000 Sep; 65(1):5-13. PubMed ID: 10936857
[TBL] [Abstract][Full Text] [Related]
23. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
[TBL] [Abstract][Full Text] [Related]
24. Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant.
Lapadat R; Tower RL; Tam W; Orazi A; Gheorghe G
Pediatr Blood Cancer; 2016 May; 63(5):935-7. PubMed ID: 26773805
[TBL] [Abstract][Full Text] [Related]
25. [Clinical features of pure erythroid leukemia--case report and review of literature].
Zhang YM; Wu DP; Sun YM; Lu SH; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):293-5. PubMed ID: 18844063
[TBL] [Abstract][Full Text] [Related]
26. [The prognosis and cytogenetic characteristics of acute erythroid leukemia: a report of 55 cases].
Liu J; Lu DP; Zhang Y
Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):738-40. PubMed ID: 17166448
[TBL] [Abstract][Full Text] [Related]
27. A History and Current Understanding of Acute Erythroid Leukemia.
Alexander C
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):583-588. PubMed ID: 37246017
[TBL] [Abstract][Full Text] [Related]
28. Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.
Cervera N; Carbuccia N; Mozziconacci MJ; Adélaïde J; Garnier S; Guille A; Murati A; Chaffanet M; Vey N; Birnbaum D; Gelsi-Boyer V
Blood Cancer J; 2017 Aug; 7(8):e594. PubMed ID: 28841205
[No Abstract] [Full Text] [Related]
29. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
30. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R.
Li B; Liu J; Qu S; Gale RP; Song Z; Xing R; Liu J; Ren Y; Xu Z; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Hu N; Cai W; Zhang P; Huang G; Xiao Z
Oncotarget; 2016 Oct; 7(42):68023-68032. PubMed ID: 27655727
[TBL] [Abstract][Full Text] [Related]
31. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
[TBL] [Abstract][Full Text] [Related]
32. Acute erythroid leukemia: autopsy report of a rare disease.
Ferreira CR; Lima FR; Goto EH; Kim EIM; Smeili LAA; de Campos FPF; Zerbini MCN
Autops Case Rep; 2011; 1(4):11-20. PubMed ID: 31528548
[TBL] [Abstract][Full Text] [Related]
33. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.
Gauthier J; Damaj G; Langlois C; Robin M; Michallet M; Chevallier P; Beguin Y; N'guyen S; Bories P; Blaise D; Cornillon J; Clavert A; Mohty M; Huynh A; Thiébaut-Bertrand A; Vigouroux S; Duhamel A; Yakoub-Agha I
Transplantation; 2015 Aug; 99(8):1672-80. PubMed ID: 25769079
[TBL] [Abstract][Full Text] [Related]
34. Acute erythroleukemia: diagnosis and management.
Santos FP; Bueso-Ramos CE; Ravandi F
Expert Rev Hematol; 2010 Dec; 3(6):705-18. PubMed ID: 21091147
[TBL] [Abstract][Full Text] [Related]
35. Acute erythroid leukemia (M6): outcome of bone marrow transplantation.
Killick S; Matutes E; Powles RL; Min T; Treleaven JG; Rege KP; Atra A; Catovsky D
Leuk Lymphoma; 1999 Sep; 35(1-2):99-107. PubMed ID: 10512167
[TBL] [Abstract][Full Text] [Related]
36. [Erythroleukemias. Recategorization according to the World Health Organization's criteria].
Peruzzo LB; Bertone MC; Mathey MD; Rossi JG; Baialardo EM; Felice MS
Medicina (B Aires); 2019; 79(1):1-5. PubMed ID: 30694182
[TBL] [Abstract][Full Text] [Related]
37. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
[TBL] [Abstract][Full Text] [Related]
38. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
Wang SA; Hasserjian RP
Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
[TBL] [Abstract][Full Text] [Related]
39. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
40. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
